REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 186 filers reported holding REGENXBIO INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $566,899 | -17.7% | 34,441 | -0.0% | 0.02% | -16.0% |
| Q2 2023 | $688,775 | +22.0% | 34,456 | +15.4% | 0.02% | +31.6% |
| Q1 2023 | $564,388 | +9.8% | 29,846 | +31.6% | 0.02% | +5.6% |
| Q4 2022 | $514,178 | -14.6% | 22,671 | -0.5% | 0.02% | -21.7% |
| Q3 2022 | $602,000 | -2.0% | 22,778 | -8.3% | 0.02% | +9.5% |
| Q2 2022 | $614,000 | -25.0% | 24,848 | +0.7% | 0.02% | -16.0% |
| Q1 2022 | $819,000 | +1.4% | 24,671 | -0.1% | 0.02% | +8.7% |
| Q4 2021 | $808,000 | -22.3% | 24,696 | -0.5% | 0.02% | -25.8% |
| Q3 2021 | $1,040,000 | +11.9% | 24,813 | +3.8% | 0.03% | +10.7% |
| Q2 2021 | $929,000 | +14.5% | 23,907 | +0.6% | 0.03% | +7.7% |
| Q1 2021 | $811,000 | +255.7% | 23,765 | +647.3% | 0.03% | +73.3% |
| Q2 2018 | $228,000 | – | 3,180 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 831,014 | $15,714,475 | 6.51% |
| MPM BioImpact LLC | 617,671 | $11,680,159 | 3.03% |
| Sonic GP LLC | 193,079 | $3,651,124 | 2.79% |
| ArchPoint Investors | 224,278 | $4,241,097 | 1.84% |
| Redmile Group, LLC | 1,640,725 | $31,026,110 | 1.35% |
| MIRABELLA FINANCIAL SERVICES LLP | 25,983 | $5,461,344 | 0.83% |
| WS MANAGEMENT LLLP | 396,997 | $7,507,213 | 0.79% |
| Redwood Wealth Management Group, LLC | 15,190 | $287,243 | 0.33% |
| SummerHaven Investment Management, LLC | 27,503 | $520,082 | 0.30% |
| Lombard Odier Asset Management (Switzerland) SA | 130,369 | $2,465,278 | 0.22% |